Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuen Chan

Showing results (221-230 of 418) with videos related to

Pageof 42
Sort By:
Translational Psychiatry|October 5, 2019
Lrrc7 mutant mice model developmental emotional dysregulation that can be alleviated by mGluR5 allosteric modulationChi Ho Chong, Qi Li, Priscilla Hoi Shan Mak, et al.
Journal of Gastroenterology and Hepatology|February 8, 2020
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis BTerry Cheuk-Fung Yip, Hye Won Lee, Vincent Wai-Sun Wong, et al.
World Journal of Gastroenterology|September 26, 2022
Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinomaJuliane Malik, Martin Klammer, Vinzent Rolny, et al.
Scientific Reports|January 14, 2014
The nucleosome assembly protein TSPYL2 regulates the expression of NMDA receptor subunits GluN2A and GluN2BKa Hing Tsang, Suk King Lai, Qi Li, et al.
World Journal of Gastroenterology|December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatmentHenry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Antiviral Therapy|July 22, 2006
Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Alex Yui Hui, et al.
Plos One|August 5, 2011
The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activityMan-Shan Li, Terrence Chi-Kong Lau, Sophie Ka-Ping Chan, et al.
Journal of Gastroenterology and Hepatology|February 2, 2019
Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapyGrace Lai-Hung Wong, Henry Lik-Yuen Chan, Ching-Kong Loo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisHwai-I Yang, Tai-Chung Tseng, Jessica Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 7, 2007
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment responseHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Ada Mei-Ling Tse, et al.
Pageof 42

Showing results (221-230 of 418) with videos related to

Sort By:
Pageof 42
Translational Psychiatry|October 5, 2019
Lrrc7 mutant mice model developmental emotional dysregulation that can be alleviated by mGluR5 allosteric modulationChi Ho Chong, Qi Li, Priscilla Hoi Shan Mak, et al.
Journal of Gastroenterology and Hepatology|February 8, 2020
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis BTerry Cheuk-Fung Yip, Hye Won Lee, Vincent Wai-Sun Wong, et al.
World Journal of Gastroenterology|September 26, 2022
Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinomaJuliane Malik, Martin Klammer, Vinzent Rolny, et al.
Scientific Reports|January 14, 2014
The nucleosome assembly protein TSPYL2 regulates the expression of NMDA receptor subunits GluN2A and GluN2BKa Hing Tsang, Suk King Lai, Qi Li, et al.
World Journal of Gastroenterology|December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatmentHenry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Antiviral Therapy|July 22, 2006
Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Alex Yui Hui, et al.
Plos One|August 5, 2011
The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activityMan-Shan Li, Terrence Chi-Kong Lau, Sophie Ka-Ping Chan, et al.
Journal of Gastroenterology and Hepatology|February 2, 2019
Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapyGrace Lai-Hung Wong, Henry Lik-Yuen Chan, Ching-Kong Loo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisHwai-I Yang, Tai-Chung Tseng, Jessica Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 7, 2007
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment responseHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Ada Mei-Ling Tse, et al.
Pageof 42